Consistently, the FXR expression was significantly increased in non-small cell lung cancer (NSCLC), which stimulated tumor growth through the direct transactivation of the cyclin D1 (CCND1) gene [108]. This evidence concerns the gene CCND1 and non-small cell lung carcinoma.